NORTHWEST BIOTHERAPEUTICS INC Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NORTHWEST BIOTHERAPEUTICS INC shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-06-30 was $181.00K, a 50.27% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-03-31 was $288.00K, a 25.19% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-12-31 was $185.00K, a 59.25% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-09-30 was $273.00K, a 60.15% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2025 was $1.21M, a 65.08% decline from fiscal 2024.
- NORTHWEST BIOTHERAPEUTICS INC shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2024 was $3.46M, a 17.28% decline from fiscal 2023.
- NORTHWEST BIOTHERAPEUTICS INC shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $4.18M.
- NORTHWEST BIOTHERAPEUTICS INC shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2016 was $127.00K, a 99.69% decline from fiscal 2015.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $181.00K 10-Q · filed 2026-08-14 | $927.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $288.00K 10-Q · filed 2026-05-15 | $1.11M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.21M 10-K · filed 2026-04-15 |
| 2025-09-30 | $273.00K 10-Q · filed 2025-11-14 | $1.48M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $364.00K 10-Q · filed 2026-08-14 | $1.89M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $385.00K 10-Q · filed 2026-05-15 | $2.68M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $454.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $3.46M 10-K · filed 2026-04-15 |
| 2024-09-30 | $685.00K 10-Q · filed 2025-11-14 | $4.51M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $1.15M 10-Q · filed 2025-08-14 | $5.39M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $1.16M 10-Q · filed 2025-05-15 | $4.42M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.18M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.56M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $190.00K 10-Q · filed 2024-08-09 | |
| 2016-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-17 | $127.00K 10-K · filed 2018-04-17 |
| 2016-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2015-12-31 | $37.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | $40.77M 10-K · filed 2016-03-16 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | |
| 2015-06-30 | -$2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2015-03-31 | $6.36M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $8.66M 10-K · filed 2016-03-16 | |
| 2014-09-30 | $871.00K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $2.66M 10-Q · filed 2014-11-19 | |
| 2014-03-31 | $2.46M 10-Q · filed 2014-11-19 |